Cargando…

Deep learning‐based survival analysis for brain metastasis patients with the national cancer database

PURPOSE: Prognostic indices such as the Brain Metastasis Graded Prognostic Assessment have been used in clinical settings to aid physicians and patients in determining an appropriate treatment regimen. These indices are derivative of traditional survival analysis techniques such as Cox proportional...

Descripción completa

Detalles Bibliográficos
Autores principales: Bice, Noah, Kirby, Neil, Bahr, Tyler, Rasmussen, Karl, Saenz, Daniel, Wagner, Timothy, Papanikolaou, Niko, Fakhreddine, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081512/
https://www.ncbi.nlm.nih.gov/pubmed/32790207
http://dx.doi.org/10.1002/acm2.12995
_version_ 1785021139587694592
author Bice, Noah
Kirby, Neil
Bahr, Tyler
Rasmussen, Karl
Saenz, Daniel
Wagner, Timothy
Papanikolaou, Niko
Fakhreddine, Mohamad
author_facet Bice, Noah
Kirby, Neil
Bahr, Tyler
Rasmussen, Karl
Saenz, Daniel
Wagner, Timothy
Papanikolaou, Niko
Fakhreddine, Mohamad
author_sort Bice, Noah
collection PubMed
description PURPOSE: Prognostic indices such as the Brain Metastasis Graded Prognostic Assessment have been used in clinical settings to aid physicians and patients in determining an appropriate treatment regimen. These indices are derivative of traditional survival analysis techniques such as Cox proportional hazards (CPH) and recursive partitioning analysis (RPA). Previous studies have shown that by evaluating CPH risk with a nonlinear deep neural network, DeepSurv, patient survival can be modeled more accurately. In this work, we apply DeepSurv to a test case: breast cancer patients with brain metastases who have received stereotactic radiosurgery. METHODS: Survival times, censorship status, and 27 covariates including age, staging information, and hormone receptor status were provided for 1673 patients by the NCDB. Monte Carlo cross‐validation with 50 samples of 1400 patients was used to train and validate the DeepSurv, CPH, and RPA models independently. DeepSurv was implemented with L2 regularization, batch normalization, dropout, Nesterov momentum, and learning rate decay. RPA was implemented as a random survival forest (RSF). Concordance indices of test sets of 140 patients were used for each sample to assess the generalizable predictive capacity of each model. RESULTS: Following hyperparameter tuning, DeepSurv was trained at 32 min per sample on a 1.33 GHz quad‐core CPU. Test set concordance indices of 0.7488 ± 0.0049, 0.6251 ± 0.0047, and 0.7368 ± 0.0047, were found for DeepSurv, CPH, and RSF, respectively. A Tukey HSD test demonstrates a statistically significant difference between the mean concordance indices of the three models. CONCLUSION: Our results suggest that deep learning‐based survival prediction can outperform traditional models, specifically in a case where an accurate prognosis is highly clinically relevant. We recommend that where appropriate data are available, deep learning‐based prognostic indicators should be used to supplement classical statistics.
format Online
Article
Text
id pubmed-10081512
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-100815122023-04-07 Deep learning‐based survival analysis for brain metastasis patients with the national cancer database Bice, Noah Kirby, Neil Bahr, Tyler Rasmussen, Karl Saenz, Daniel Wagner, Timothy Papanikolaou, Niko Fakhreddine, Mohamad J Appl Clin Med Phys Radiation Oncology Physics PURPOSE: Prognostic indices such as the Brain Metastasis Graded Prognostic Assessment have been used in clinical settings to aid physicians and patients in determining an appropriate treatment regimen. These indices are derivative of traditional survival analysis techniques such as Cox proportional hazards (CPH) and recursive partitioning analysis (RPA). Previous studies have shown that by evaluating CPH risk with a nonlinear deep neural network, DeepSurv, patient survival can be modeled more accurately. In this work, we apply DeepSurv to a test case: breast cancer patients with brain metastases who have received stereotactic radiosurgery. METHODS: Survival times, censorship status, and 27 covariates including age, staging information, and hormone receptor status were provided for 1673 patients by the NCDB. Monte Carlo cross‐validation with 50 samples of 1400 patients was used to train and validate the DeepSurv, CPH, and RPA models independently. DeepSurv was implemented with L2 regularization, batch normalization, dropout, Nesterov momentum, and learning rate decay. RPA was implemented as a random survival forest (RSF). Concordance indices of test sets of 140 patients were used for each sample to assess the generalizable predictive capacity of each model. RESULTS: Following hyperparameter tuning, DeepSurv was trained at 32 min per sample on a 1.33 GHz quad‐core CPU. Test set concordance indices of 0.7488 ± 0.0049, 0.6251 ± 0.0047, and 0.7368 ± 0.0047, were found for DeepSurv, CPH, and RSF, respectively. A Tukey HSD test demonstrates a statistically significant difference between the mean concordance indices of the three models. CONCLUSION: Our results suggest that deep learning‐based survival prediction can outperform traditional models, specifically in a case where an accurate prognosis is highly clinically relevant. We recommend that where appropriate data are available, deep learning‐based prognostic indicators should be used to supplement classical statistics. John Wiley and Sons Inc. 2020-08-13 /pmc/articles/PMC10081512/ /pubmed/32790207 http://dx.doi.org/10.1002/acm2.12995 Text en © 2020 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals LLC on behalf of American Association of Physicists in Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Radiation Oncology Physics
Bice, Noah
Kirby, Neil
Bahr, Tyler
Rasmussen, Karl
Saenz, Daniel
Wagner, Timothy
Papanikolaou, Niko
Fakhreddine, Mohamad
Deep learning‐based survival analysis for brain metastasis patients with the national cancer database
title Deep learning‐based survival analysis for brain metastasis patients with the national cancer database
title_full Deep learning‐based survival analysis for brain metastasis patients with the national cancer database
title_fullStr Deep learning‐based survival analysis for brain metastasis patients with the national cancer database
title_full_unstemmed Deep learning‐based survival analysis for brain metastasis patients with the national cancer database
title_short Deep learning‐based survival analysis for brain metastasis patients with the national cancer database
title_sort deep learning‐based survival analysis for brain metastasis patients with the national cancer database
topic Radiation Oncology Physics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081512/
https://www.ncbi.nlm.nih.gov/pubmed/32790207
http://dx.doi.org/10.1002/acm2.12995
work_keys_str_mv AT bicenoah deeplearningbasedsurvivalanalysisforbrainmetastasispatientswiththenationalcancerdatabase
AT kirbyneil deeplearningbasedsurvivalanalysisforbrainmetastasispatientswiththenationalcancerdatabase
AT bahrtyler deeplearningbasedsurvivalanalysisforbrainmetastasispatientswiththenationalcancerdatabase
AT rasmussenkarl deeplearningbasedsurvivalanalysisforbrainmetastasispatientswiththenationalcancerdatabase
AT saenzdaniel deeplearningbasedsurvivalanalysisforbrainmetastasispatientswiththenationalcancerdatabase
AT wagnertimothy deeplearningbasedsurvivalanalysisforbrainmetastasispatientswiththenationalcancerdatabase
AT papanikolaouniko deeplearningbasedsurvivalanalysisforbrainmetastasispatientswiththenationalcancerdatabase
AT fakhreddinemohamad deeplearningbasedsurvivalanalysisforbrainmetastasispatientswiththenationalcancerdatabase